常山药业(300255.SZ)：实际控制人拟协议转让5.0051%股份

Core Viewpoint - Changshan Pharmaceutical (300255.SZ) announced that its controlling shareholder, Mr. Gao Shuhua, has signed a share transfer agreement with Element Fund, planning to transfer 46,000,000 unrestricted circulating shares, representing 5.0051% of the company's total share capital, at a price of 46.25 yuan per share [1] Group 1 - The share transfer agreement is set to be executed on November 20, 2025 [1] - The shares being transferred are part of the holdings of the actual controller of the company [1] - The transaction price reflects a significant valuation of the shares at 46.25 yuan each [1]